Deferred Tax Assets, Valuation Allowance of NovoCure Ltd from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NovoCure Ltd quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • NovoCure Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $1,833,239,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

NovoCure Ltd Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,833,239,000 +$196,406,000 +12% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $1,636,833,000 +$1,261,458,000 +336% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $375,375,000 +$14,017,000 +3.9% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $361,358,000 -$14,359,000 -3.8% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 $375,717,000 +$11,635,000 +3.2% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q4 2020 $364,082,000 +$7,070,000 +2% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 $357,012,000 +$244,652,000 +218% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $112,360,000 +$36,556,000 +48% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q4 2017 $75,804,000 +$5,743,000 +8.2% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 $70,061,000 +$36,585,000 +109% 31 Dec 2016 10-K 22 Feb 2018 2017 FY
Q4 2015 $33,476,000 +$19,550,000 +140% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q4 2014 $13,926,000 31 Dec 2014 10-K 01 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.